State Opioid Response Grant Authorization Act (HR 2466, 116th Congress)

Policy Details

Policy Details

Originating Entity
Last Action
Referred to Committee
Date of Last Action
May 1 2019
Congressional Session
116th Congress
Date Introduced
May 1 2019
Publication Date
May 10 2019

SciPol Summary

The State Opioid Response Grant Authorization Act (HR 2466, 116th Congress) would authorize $1 billion annually for fiscal years 2020 through 2024 to address the ongoing opioid crisis. The Act states that these funds would be authorized in the same fashion as was appropriated in the Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriation Act in 2018 (Public Law 115-141). Out of the $1 billion authorized for appropriation, the Act specifies that at least $50 million would be earmarked for Indian tribal groups.

The ongoing opioid crisis in the US has prompted action from both the executive and legislative branches to address the estimated 130 individuals who die every day by opioid overdose. The most substantial government action to date was the passage of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (Public Law 115-271; SciPol Full Brief) in October 2018. In the 116th Congress, various legislative proposals — ranging from authorizing appropriations to limiting the ability of the Food and Drug Administration to approve new opioid drugs to expanding availability of opioid overdose medication — have been introduced.

SciPol Summary authored by